Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status

Identifieur interne : 000330 ( 2020/Analysis ); précédent : 000329; suivant : 000331

Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status

Auteurs : Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]

Source :

RBID : PMC:7166307

Abstract

Coronaviruses are a large group of viruses known to cause illnesses that vary between the common cold and more severe diseases to include severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). A novel coronavirus was identified in December 2019 in Wuhan city, Hubei province, China. This virus represents a new strain that has not been previously identified in humans. The virus is now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting disease is called coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) declared the novel coronavirus outbreak a global pandemic in March 2020. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with more than 1,948,617 laboratory-confirmed cases and over 121,846 deaths worldwide. Currently, no specific medication is recommended to treat COVID-19 patients. However, governments and pharmaceutical companies are struggling to quickly find an effective drug to defeat the coronavirus. In the current review, we summarize the existing state of knowledge about COVID-19, available medications, and treatment options. Favilavir is an antiviral drug that is approved in Japan for common influenza treatment and is now approved to treat symptoms of COVID-19 in China. Moreover, Chloroquine and hydroxychloroquine, drugs used to treat malaria and arthritis, respectively, were recommended by the National Health Commission of the People's Republic of China for treatment of COVID-19. Presently, chloroquine and hydroxychloroquine are under investigation by the US Food and Drug Administration (FDA) as a treatment for COVID-19. The first COVID-19 vaccine is not expected to be ready for clinical trials before the end of the year.


Url:
DOI: 10.1016/j.meegid.2020.104327
PubMed: NONE
PubMed Central: 7166307


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:7166307

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status</title>
<author>
<name sortKey="El Aziz, Tarek Mohamed Abd" sort="El Aziz, Tarek Mohamed Abd" uniqKey="El Aziz T" first="Tarek Mohamed Abd" last="El-Aziz">Tarek Mohamed Abd El-Aziz</name>
<affiliation wicri:level="2">
<nlm:aff id="af0005">Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="af0010">Zoology Department, Faculty of Science, Minia University, El-Minia 61519, Egypt</nlm:aff>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>Zoology Department, Faculty of Science, Minia University, El-Minia 61519</wicri:regionArea>
<wicri:noRegion>El-Minia 61519</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Stockand, James D" sort="Stockand, James D" uniqKey="Stockand J" first="James D." last="Stockand">James D. Stockand</name>
<affiliation wicri:level="2">
<nlm:aff id="af0005">Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmc">7166307</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166307</idno>
<idno type="RBID">PMC:7166307</idno>
<idno type="doi">10.1016/j.meegid.2020.104327</idno>
<idno type="pmid">NONE</idno>
<date when="2020">2020</date>
<idno type="wicri:Area/Pmc/Corpus">001788</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001788</idno>
<idno type="wicri:Area/Pmc/Curation">001788</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001788</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000116</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000116</idno>
<idno type="wicri:Area/Ncbi/Merge">003F85</idno>
<idno type="wicri:Area/Ncbi/Curation">003F85</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003F85</idno>
<idno type="wicri:doubleKey">1567-1348:2020:El Aziz T:recent:progress:and</idno>
<idno type="wicri:Area/Main/Merge">000330</idno>
<idno type="wicri:Area/Main/Curation">000330</idno>
<idno type="wicri:Area/Main/Exploration">000330</idno>
<idno type="wicri:Area/2020/Extraction">000330</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status</title>
<author>
<name sortKey="El Aziz, Tarek Mohamed Abd" sort="El Aziz, Tarek Mohamed Abd" uniqKey="El Aziz T" first="Tarek Mohamed Abd" last="El-Aziz">Tarek Mohamed Abd El-Aziz</name>
<affiliation wicri:level="2">
<nlm:aff id="af0005">Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="af0010">Zoology Department, Faculty of Science, Minia University, El-Minia 61519, Egypt</nlm:aff>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>Zoology Department, Faculty of Science, Minia University, El-Minia 61519</wicri:regionArea>
<wicri:noRegion>El-Minia 61519</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Stockand, James D" sort="Stockand, James D" uniqKey="Stockand J" first="James D." last="Stockand">James D. Stockand</name>
<affiliation wicri:level="2">
<nlm:aff id="af0005">Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Infection, Genetics and Evolution</title>
<idno type="ISSN">1567-1348</idno>
<idno type="eISSN">1567-7257</idno>
<imprint>
<date when="2020">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Coronaviruses are a large group of viruses known to cause illnesses that vary between the common cold and more severe diseases to include severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). A novel coronavirus was identified in December 2019 in Wuhan city, Hubei province, China. This virus represents a new strain that has not been previously identified in humans. The virus is now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting disease is called coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) declared the novel coronavirus outbreak a global pandemic in March 2020. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with more than 1,948,617 laboratory-confirmed cases and over 121,846 deaths worldwide. Currently, no specific medication is recommended to treat COVID-19 patients. However, governments and pharmaceutical companies are struggling to quickly find an effective drug to defeat the coronavirus. In the current review, we summarize the existing state of knowledge about COVID-19, available medications, and treatment options. Favilavir is an antiviral drug that is approved in Japan for common influenza treatment and is now approved to treat symptoms of COVID-19 in China. Moreover, Chloroquine and hydroxychloroquine, drugs used to treat malaria and arthritis, respectively, were recommended by the National Health Commission of the People's Republic of China for treatment of COVID-19. Presently, chloroquine and hydroxychloroquine are under investigation by the US Food and Drug Administration (FDA) as a treatment for COVID-19. The first COVID-19 vaccine is not expected to be ready for clinical trials before the end of the year.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Adnan Shereen, M" uniqKey="Adnan Shereen M">M. Adnan Shereen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Alharbi, N K" uniqKey="Alharbi N">N.K. Alharbi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Assiri, A" uniqKey="Assiri A">A. Assiri</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bassetti, M" uniqKey="Bassetti M">M. Bassetti</name>
</author>
<author>
<name sortKey="Vena, A" uniqKey="Vena A">A. Vena</name>
</author>
<author>
<name sortKey="Giacobbe, D R" uniqKey="Giacobbe D">D.R. Giacobbe</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Caly, L" uniqKey="Caly L">L. Caly</name>
</author>
<author>
<name sortKey="The Fda Approved Drug Ivermectin Inhibits The Replication Of Sars Cov In Vitro" uniqKey="The Fda Approved Drug Ivermectin Inhibits The Replication Of Sars Cov In Vitro">The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cao, B" uniqKey="Cao B">B. Cao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Carlos, W G" uniqKey="Carlos W">W.G. Carlos</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cascella, M" uniqKey="Cascella M">M. Cascella</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chan, J F W" uniqKey="Chan J">J.F.-W. Chan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chan, K S" uniqKey="Chan K">K.S. Chan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, H" uniqKey="Chen H">H. Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, L" uniqKey="Chen L">L. Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, N" uniqKey="Chen N">N. Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, N" uniqKey="Chen N">N. Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, W" uniqKey="Chen W">W. Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cheng, Y" uniqKey="Cheng Y">Y. Cheng</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Christian, M D" uniqKey="Christian M">M.D. Christian</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chu, C M" uniqKey="Chu C">C.M. Chu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Covid In Children" uniqKey="Covid In Children">COVID-19 in Children</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Crouch, E C" uniqKey="Crouch E">E.C. Crouch</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cui, J" uniqKey="Cui J">J. Cui</name>
</author>
<author>
<name sortKey="Li, F" uniqKey="Li F">F. Li</name>
</author>
<author>
<name sortKey="Shi, Z L" uniqKey="Shi Z">Z.L. Shi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dong, L" uniqKey="Dong L">L. Dong</name>
</author>
<author>
<name sortKey="Hu, S" uniqKey="Hu S">S. Hu</name>
</author>
<author>
<name sortKey="Gao, J" uniqKey="Gao J">J. Gao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dong, L" uniqKey="Dong L">L. Dong</name>
</author>
<author>
<name sortKey="Hu, S" uniqKey="Hu S">S. Hu</name>
</author>
<author>
<name sortKey="Gao, J" uniqKey="Gao J">J. Gao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Van Doremalen, N" uniqKey="Van Doremalen N">N. van Doremalen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Duan, K" uniqKey="Duan K">K. Duan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Elfiky, A A" uniqKey="Elfiky A">A.A. Elfiky</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Falsey, A R" uniqKey="Falsey A">A.R. Falsey</name>
</author>
<author>
<name sortKey="Walsh, E E" uniqKey="Walsh E">E.E. Walsh</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fan, C" uniqKey="Fan C">C. Fan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gao, J" uniqKey="Gao J">J. Gao</name>
</author>
<author>
<name sortKey="Tian, Z" uniqKey="Tian Z">Z. Tian</name>
</author>
<author>
<name sortKey="Yang, X" uniqKey="Yang X">X. Yang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gu, J" uniqKey="Gu J">J. Gu</name>
</author>
<author>
<name sortKey="Han, B" uniqKey="Han B">B. Han</name>
</author>
<author>
<name sortKey="Wang, J" uniqKey="Wang J">J. Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Guan, W J" uniqKey="Guan W">W.J. Guan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Guan, Y" uniqKey="Guan Y">Y. Guan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Holshue, M L" uniqKey="Holshue M">M.L. Holshue</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Huang, C" uniqKey="Huang C">C. Huang</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jawhara, S" uniqKey="Jawhara S">S. Jawhara</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ji, W" uniqKey="Ji W">W. Ji</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jin, Y H" uniqKey="Jin Y">Y.-H. Jin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kliegman, R M" uniqKey="Kliegman R">R.M. Kliegman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lee, P I" uniqKey="Lee P">P.-I. Lee</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lei, J" uniqKey="Lei J">J. Lei</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, G" uniqKey="Li G">G. Li</name>
</author>
<author>
<name sortKey="De Clercq, E" uniqKey="De Clercq E">E. De Clercq</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, H" uniqKey="Li H">H. Li</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, Q" uniqKey="Li Q">Q. Li</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, Z" uniqKey="Li Z">Z. Li</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lim, J" uniqKey="Lim J">J. Lim</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Liu, L" uniqKey="Liu L">L. Liu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lu, H" uniqKey="Lu H">H. Lu</name>
</author>
<author>
<name sortKey="Stratton, C W" uniqKey="Stratton C">C.W. Stratton</name>
</author>
<author>
<name sortKey="Tang, Y W" uniqKey="Tang Y">Y.-W. Tang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ludvigsson, J F" uniqKey="Ludvigsson J">J.F. Ludvigsson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Maclennan, S" uniqKey="Maclennan S">S. MacLennan</name>
</author>
<author>
<name sortKey="Barbara, J A" uniqKey="Barbara J">J.A. Barbara</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mahase, E" uniqKey="Mahase E">E. Mahase</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Maxwell, C" uniqKey="Maxwell C">C. Maxwell</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nijuan, X" uniqKey="Nijuan X">X. Nijuan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Onder, G" uniqKey="Onder G">G. Onder</name>
</author>
<author>
<name sortKey="Rezza, G" uniqKey="Rezza G">G. Rezza</name>
</author>
<author>
<name sortKey="Brusaferro, S" uniqKey="Brusaferro S">S. Brusaferro</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Organization W H" uniqKey="Organization W H">Organization, W.H</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Phan, L T" uniqKey="Phan L">L.T. Phan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rabenau, H F" uniqKey="Rabenau H">H.F. Rabenau</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Raj, V S" uniqKey="Raj V">V.S. Raj</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rayner, C R" uniqKey="Rayner C">C.R. Rayner</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Riou, J" uniqKey="Riou J">J. Riou</name>
</author>
<author>
<name sortKey="Althaus, C L" uniqKey="Althaus C">C.L. Althaus</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Roldao, A" uniqKey="Roldao A">A. Roldao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Saglietto, A" uniqKey="Saglietto A">A. Saglietto</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Schwartz, D A" uniqKey="Schwartz D">D.A. Schwartz</name>
</author>
<author>
<name sortKey="Graham, A L" uniqKey="Graham A">A.L. Graham</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shimabukuro Vornhagen, A" uniqKey="Shimabukuro Vornhagen A">A. Shimabukuro-Vornhagen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sodhi, M" uniqKey="Sodhi M">M. Sodhi</name>
</author>
<author>
<name sortKey="Etminan, M" uniqKey="Etminan M">M. Etminan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sohrabi, C" uniqKey="Sohrabi C">C. Sohrabi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Su, S" uniqKey="Su S">S. Su</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Van Griensven, J" uniqKey="Van Griensven J">J. Van Griensven</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, J" uniqKey="Wang J">J. Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, L S" uniqKey="Wang L">L.S. Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, M" uniqKey="Wang M">M. Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, P" uniqKey="Wang P">P. Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, W" uniqKey="Wang W">W. Wang</name>
</author>
<author>
<name sortKey="Tang, J" uniqKey="Tang J">J. Tang</name>
</author>
<author>
<name sortKey="Wei, F" uniqKey="Wei F">F. Wei</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Webster, R G" uniqKey="Webster R">R.G. Webster</name>
</author>
<author>
<name sortKey="Govorkova, E A" uniqKey="Govorkova E">E.A. Govorkova</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Weiss, S R" uniqKey="Weiss S">S.R. Weiss</name>
</author>
<author>
<name sortKey="Navas Martin, S" uniqKey="Navas Martin S">S. Navas-Martin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Whitworth, J" uniqKey="Whitworth J">J. Whitworth</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wu, Z" uniqKey="Wu Z">Z. Wu</name>
</author>
<author>
<name sortKey="Mcgoogan, J M" uniqKey="Mcgoogan J">J.M. McGoogan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Xiao, F" uniqKey="Xiao F">F. Xiao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Xiao, Y" uniqKey="Xiao Y">Y. Xiao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yang, S" uniqKey="Yang S">S. Yang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yang, Y" uniqKey="Yang Y">Y. Yang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhang, C" uniqKey="Zhang C">C. Zhang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhang, Q" uniqKey="Zhang Q">Q. Zhang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhang, T" uniqKey="Zhang T">T. Zhang</name>
</author>
<author>
<name sortKey="Wu, Q" uniqKey="Wu Q">Q. Wu</name>
</author>
<author>
<name sortKey="Zhang, Z" uniqKey="Zhang Z">Z. Zhang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhang, Y" uniqKey="Zhang Y">Y. Zhang</name>
</author>
<author>
<name sortKey="Xu, J M" uniqKey="Xu J">J.M. Xu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zheng, F" uniqKey="Zheng F">F. Zheng</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhou, P" uniqKey="Zhou P">P. Zhou</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhou, Y" uniqKey="Zhou Y">Y. Zhou</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zu, Z Y" uniqKey="Zu Z">Z.Y. Zu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zumla, A" uniqKey="Zumla A">A. Zumla</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations>
<list>
<country>
<li>Égypte</li>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Texas">
<name sortKey="El Aziz, Tarek Mohamed Abd" sort="El Aziz, Tarek Mohamed Abd" uniqKey="El Aziz T" first="Tarek Mohamed Abd" last="El-Aziz">Tarek Mohamed Abd El-Aziz</name>
</region>
<name sortKey="Stockand, James D" sort="Stockand, James D" uniqKey="Stockand J" first="James D." last="Stockand">James D. Stockand</name>
</country>
<country name="Égypte">
<noRegion>
<name sortKey="El Aziz, Tarek Mohamed Abd" sort="El Aziz, Tarek Mohamed Abd" uniqKey="El Aziz T" first="Tarek Mohamed Abd" last="El-Aziz">Tarek Mohamed Abd El-Aziz</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000330 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000330 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    RBID
   |clé=     PMC:7166307
   |texte=   Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i   -Sk "pubmed:NONE" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021